BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23319255)

  • 41. A comparison of swallowing dysfunction after three-dimensional conformal and intensity-modulated radiotherapy : A systematic review by the Italian Head and Neck Radiotherapy Study Group.
    Ursino S; D'Angelo E; Mazzola R; Merlotti A; Morganti R; Cristaudo A; Paiar F; Musio D; Alterio D; Bacigalupo A; Russi EG; Lohr F
    Strahlenther Onkol; 2017 Nov; 193(11):877-889. PubMed ID: 28616822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of early and late dysphagia using videofluoroscopy and quality of life questionnaires in patients with head and neck cancer treated with radiation therapy.
    Erkal EY; Canoğlu D; Kaya A; Aksu G; Sarper B; Akansel G; Meydancı T; Erkal HS
    Radiat Oncol; 2014 Jun; 9():137. PubMed ID: 24928361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer.
    Langendijk JA; Doornaert P; Rietveld DH; Verdonck-de Leeuw IM; Leemans CR; Slotman BJ
    Radiother Oncol; 2009 Feb; 90(2):189-95. PubMed ID: 19167120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes.
    Werbrouck J; De Ruyck K; Duprez F; Veldeman L; Claes K; Van Eijkeren M; Boterberg T; Willems P; Vral A; De Neve W; Thierens H
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1187-95. PubMed ID: 19251090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identifying organs at risk for radiation-induced late dysphagia in head and neck cancer patients.
    Hedström J; Tuomi L; Finizia C; Olsson C
    Clin Transl Radiat Oncol; 2019 Nov; 19():87-95. PubMed ID: 31646203
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of methods to reduce dose to swallowing-related structures in head and neck cancer.
    Caudell JJ; Burnett OL; Schaner PE; Bonner JA; Duan J
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):462-7. PubMed ID: 19577862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sparing Swallowing-Related Structures Reduces Post-Radiotherapy Dysphagia in Oropharyngeal Cancer.
    Wasuthalainun C; Keskool P; Petsuksiri J; Ongard S; Sureepong P
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1451-1456. PubMed ID: 38680007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dosimetric Predictors of Patient-Reported Xerostomia and Dysphagia With Deintensified Chemoradiation Therapy for HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Chera BS; Fried D; Price A; Amdur RJ; Mendenhall W; Lu C; Das S; Sheets N; Marks L; Mavroidis P
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1022-1027. PubMed ID: 28721884
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of Doses to Parotid, Temporomandibular Joint, and Pharyngeal Constrictor Muscles Using Different Techniques in Radiotherapy for Oropharyngeal Cancer.
    Yamic F; Koca T; Tuncel N; Aksoy RA; Korcum AF
    Technol Cancer Res Treat; 2024; 23():15330338241260646. PubMed ID: 38841792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiation-induced long-term dysphagia in survivors of head and neck cancer and association with dose-volume parameters.
    Huynh TM; Dale E; Falk RS; Hellebust TP; Astrup GL; Malinen E; Edin NFJ; Bjordal K; Herlofson BB; Kiserud CE; Helland Å; Amdal CD
    Radiother Oncol; 2024 Jan; 190():110044. PubMed ID: 38061420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates.
    Eisbruch A; Kim HM; Feng FY; Lyden TH; Haxer MJ; Feng M; Worden FP; Bradford CR; Prince ME; Moyer JS; Wolf GT; Chepeha DB; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e93-9. PubMed ID: 21592678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer.
    Lambrecht M; Nevens D; Nuyts S
    Strahlenther Onkol; 2013 Mar; 189(3):223-9. PubMed ID: 23319256
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
    van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
    Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and dosimetric predictors of radiation-induced esophageal toxicity.
    Maguire PD; Sibley GS; Zhou SM; Jamieson TA; Light KL; Antoine PA; Herndon JE; Anscher MS; Marks LB
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):97-103. PubMed ID: 10477012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Head and neck intensity-modulated radiation therapy: Normal tissues dose constraints. Pharyngeal constrictor muscles and larynx].
    Graff P; Woisard V; Racadot S; Thariat J; Pointreau Y
    Cancer Radiother; 2016 Oct; 20(6-7):452-8. PubMed ID: 27599684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of Dosimetric Parameters in Dysphagia Aspiration-Related Structures and Clinical Correlation in Head and Neck Cancer Patients Treated With Radiotherapy.
    Upadhyay P; Kumar P; Chauhan AK; Kumar P; Nigam J; S N
    Cureus; 2022 Jul; 14(7):e26765. PubMed ID: 35967135
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Results of fiberoptic endoscopic evaluation of swallowing vs. radiation dose in the swallowing muscles after radiotherapy of cancer in the oropharynx.
    Teguh DN; Levendag PC; Sewnaik A; Hakkesteegt MM; Noever I; Voet P; van der Est H; Sipkema D; van Rooij P; Baatenburg de Jong RJ; Schmitz PI
    Radiother Oncol; 2008 Oct; 89(1):57-63. PubMed ID: 18722028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Constraints of the dentist are consistent with the results of an optimal irradiation with modulated intensity in N0 oropharyngeal cancer].
    Jaussaud S; Guihard S; Niederst C; Borel C; Meyer P; Hémar P; Schultz P; Noël G; Féki A
    Cancer Radiother; 2013; 17(4):265-71. PubMed ID: 23726044
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluating predictive factors for toxicities experienced by head & neck cancer patients undergoing radiotherapy.
    Ray X; Sumner W; Sutton L; Sanghvi P; Deichaite I; Moiseenko V
    J Transl Med; 2021 Sep; 19(1):380. PubMed ID: 34493300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.